View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 18, 2023
10 min read
Save

'Something needs to change': ACP plans to streamline specialty referrals

'Something needs to change': ACP plans to streamline specialty referrals

The ACP has proposed a new process to streamline specialty referrals — a step that experts have called critical to fixing a massive issue in health care — but questions remain about the plan’s feasibility.

SPONSORED CONTENT
January 18, 2023
32 min listen
Save

Making Sense of Sensory Ganglionopathies, Part 2

Making Sense of Sensory Ganglionopathies, Part 2

In this episode, Dr. Benjamin Claytor walks us through his approach to suspected sensory ganglionopathies. I also cover other neurologic complications of Sjogren’s syndrome and some interesting history on vitamin B6.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
January 17, 2023
2 min read
Save

MedPAC asks Congress to increase physician payments

MedPAC asks Congress to increase physician payments

The Medicare Payment Advisory Commission, or MedPAC, has recently voted to recommend that Congress increase 2024 Medicare payments for physicians and other health services.

SPONSORED CONTENT
January 17, 2023
5 min read
Save

Sleep and COVID: Sleep-related symptoms, ‘transient’ vaccine-related side effects and more

Sleep and COVID: Sleep-related symptoms, ‘transient’ vaccine-related side effects and more

Indira Gurubhagavatula, MD, MPH, associate professor of medicine and director of the Sleep Medicine Fellowship at Penn Medicine, spoke with Healio about the relationship between COVID-19 and sleep.

SPONSORED CONTENT
January 17, 2023
1 min read
Save

Amylyx, Neopharm announce agreement to distribute oral ALS treatment in Middle East

Amylyx, Neopharm announce agreement to distribute oral ALS treatment in Middle East

Amylyx Pharmaceuticals Inc. announced an exclusive license and distribution agreement with Neopharm for the commercialization of ALS therapeutic AMX0035 in Israel, Gaza, West Bank and the Palestinian Authority.

SPONSORED CONTENT
January 17, 2023
2 min read
Save

Safety signal for COVID-19 booster unlikely to be ‘true clinical risk,’ officials say

Safety signal for COVID-19 booster unlikely to be ‘true clinical risk,’ officials say

Health officials said a safety signal detected by a national surveillance system is “very unlikely” to represent a “true clinical risk” for stroke among older people who received the Pfizer-BioNTech bivalent COVID-19 booster.

SPONSORED CONTENT
January 17, 2023
2 min read
Save

Quantitative pupillometry may be effective assessment tool in emergency setting

Quantitative pupillometry may be effective assessment tool in emergency setting

Quantitative pupillometry may be a reliable method of assessing clinically intoxicated patients in EDs, per a study published in the Journal of the American College of Emergency Physicians Open.

SPONSORED CONTENT
January 14, 2023
2 min read
Save

Cardiometabolic multimorbidity impacts dementia risk

Cardiometabolic multimorbidity impacts dementia risk

Cardiometabolic multimorbidity and midlife onset of cardiometabolic disease are significantly associated with an increased risk for dementia, and genetic background may underlie this association, researchers reported.

SPONSORED CONTENT
January 13, 2023
1 min read
Save

LinusBio raises $16M for novel platform to aid diagnosis, treatment of ALS, autism

LinusBio raises $16M for novel platform to aid diagnosis, treatment of ALS, autism

LinusBio announced it has raised over $16 million in Series A funding to deliver technology that combines genomics, the environment and biological response to help diagnose and monitor the progression of disorders such as ALS and autism.

SPONSORED CONTENT
January 13, 2023
2 min read
Save

Tenecteplase not associated with better outcome at 90 days in those with wake-up stroke

Tenecteplase not associated with better outcome at 90 days in those with wake-up stroke

Treatment with IV Tenecteplase was not associated with better functional outcome after 90 days in patients with wake-up stroke selected using advanced imaging, per a study published in The Lancet Neurology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails